The activist group called themselves “Open Ledger.”
Small. Careful. Anonymous.
They met in basements and empty parking garages, whispering about procurement fraud and defense contracts. {{user}} joined because she wanted evidence—real proof of something the public would never be told.
When a janitorial subcontract listing appeared for a federal biomedical complex outside Arlington, they saw an opening.
Fake IDs. Background checks passed through a sympathetic clerk.
Three of them went in.
The facility looked ordinary. Concrete walls. Fluorescent lights. Badges scanned at every door. The name outside read “Logistics Health Assessment Unit.”
Inside, it was different.
{{user}} pushed a supply cart past conference rooms until she heard a briefing through a cracked door.
A projection screen showed silhouettes of soldiers.
A general spoke calmly.
“Casualties are expensive. Equipment loss is unacceptable. Project Stillbody reduces kinetic engagement. Enemy combatants experience rapid adipose expansion. Mobility collapses within weeks.”
Another voice asked, “Fatalities?”
“Minimal. That is not the objective. Immobilization is.”
Slides shifted—charts, metabolic accelerants, aerosol dispersal systems.
Then came the next phase.
“Domestic adaptation potential?” a woman asked.
The room quieted.
The general nodded. “Law enforcement. Protective services. Eventual civilian compliance framework.”
A slide appeared with projected population weights: 600 to 1,000 pounds.
“Reduced civil unrest through metabolic pacification.”
{{user}}’s grip tightened on the cart handle.
That night, she accessed a lab refrigerator during inventory rounds. Small steel vials labeled: SB-9 Metabolic Catalyst.
She slipped one into her pocket.
⸻
In a storage closet, the group examined the sample.
“We need to know how fast it works,” one whispered.
“If we leak false info and it’s wrong, we’re finished,” another said.
They agreed to micro-dose.
The first days were subtle.
Hunger sharpened. Energy shifted.
By day four, uniforms tightened. Faces softened.
By day seven, the changes were undeniable.
{{user}}’s body responded aggressively. Her frame thickened. Her stomach grew heavy and firm. Walking long corridors required focus. Floors creaked under her weight.
She recorded everything—daily scale readings, lab footage stolen from a terminal, snippets of meeting audio.
But security increased.
Biometric scans appeared.
One activist failed to report for shift.
Another badge deactivated mid-day.
In the lower research wing, {{user}} glimpsed a sealed observation room. Inside, a test subject sat restrained in reinforced seating, body massively expanded, breathing through assisted ventilation.
A technician spoke into a recorder. “Subject remains conscious. Cognitive function intact. Mobility at zero.”
Footsteps echoed.
She moved, slower now, each step deliberate. Her size made stealth harder. Door frames brushed her shoulders. Stairwells strained her knees.
An alert sounded.
“Unscheduled personnel in Sector C.”
She ran as best she could. Security rounded the corner.
Hands grabbed her arms.
Her badge flashed red.
⸻
Restraints secured her to a reinforced medical platform.
A man in a suit stepped forward.
“You ingested SB-9 voluntarily,” he said.
She stared back.
“Adaptive metabolism,” he continued. “Remarkable response rate.”
The injection burned.
Hours blurred.
Her body swelled further, weight climbing beyond six hundred pounds. Limbs heavy. Movement impossible.
Machines monitored her heart rate.
Across the room, a radio crackled.
“…Department of Defense confirms deployment of non-lethal metabolic dispersal agents in overseas theaters…”
Another voice followed.
“…domestic integration under review…”
A technician adjusted a dial.
“Initial civilian compliance trials successful,” someone said.
{{user}} stared at the ceiling lights.
On a wall-mounted monitor, footage played of foreign soldiers struggling to stand, collapsing under sudden mass.
No gunfire.
No explosions.
Just immobilization.
{{user}} has failed.